Reported patients with congenital fixed dilated pupils had pupil diameters ranging from 5.5 to 7 mm. The pupils were nonreactive to light and convergence, as well as a variety of topical eye drops. The marginal portion from the collarette to the pupillary border (pars pupillaris) is absent, resulting in a scalloped pupillary margin. The remaining portion of the iris (pars ciliaris) is hypoplastic with the absence of crypts, but does not transilluminate. Numerous strands of persistent pupillary membrane extend from the collarette to the anterior lens capsule. Our Case 1 had cortical visual impairment, resulting in vision reduced to 20/50 bilaterally, but otherwise distance vision is usually good in ACTA2 patients. In most cases, accommodation is reported to be very poor (4,10).
Alpha-actin is expressed in the dilator and sphincter muscles of the normal iris (11). Optical coherence tomography of the iris and biomicroscopic imaging suggests absence of the iris sphincter muscle (Fig. 10). Absence of the concentric circular folds in the peripheral iris is consistent with absence of the pupillary dilator muscle. Absence of the pupillary sphincter and dilator muscles awaits histopathologic confirmation.
Retinal arteriolar stenosis and occlusion progressively appearing in the second decade of life is similar to the occlusive arteriolar disease occurring in the brain. SMC proliferation can progressively obstruct the vessels since the elastic lamina is lacking in retinal arteriolar walls. Möller et al (4) reported retinal vascular tortuosity with increasing age, and this could be related to vessel wall changes and loss of contractility. One of his patients also developed areas of arteriolar dilation and microvascular changes with leakage. Two of our patients (Cases 2 and 3) developed retinal vascular tortuosity. These vascular abnormalities support the experimental findings of Tomasek et al (12) that alpha-actin in the pericytes and the SMCs of the retinal vessel walls is necessary for normal retinal vascular permeability and for a normal blood–retina barrier.
There are a few published reports of children with congenital mydriasis associated with isolated patent ductus arteriosis or aorticopulmonary septal defects (13–17), but screening for ACTA2 was not performed. Systemic abnormalities in these patients included abdominal aortic aneurysm and myocardial infarction in an 8-year-old girl (16) and retinal tortuosity in 2 other patients (14,15). Neurologic status was normal, but all patients were very young (oldest was 9 years of age). Association between patent ductus arteriosus and fixed dilated pupils is suggestive of MSMDS, as alpha-actin is expressed by cardiomyocytes during heart embryogenesis between the 9th and 33rd weeks of development (18).
Recently, congenital mydriasis has been described in 2 neonates with megacystis microcolon intestinal hypoperistaltis syndrome, in association with impaired vesical and intestinal peristaltis (19). The genetic basis remains unknown as ACTA2 screening was not performed.
Fixed dilated pupils in a young child is an extremely rare condition and should alert pediatricians and ophthalmologists to the possibility of the coexistence of systemic life-threatening disorders, including MSMDS. Genetic testing is essential in evaluating this patient population.
1. Milewicz DM, Ostergaard JR, Ala-Kokko LM, Khan N, Grange DK, Mendoza-Londono R, Bradley TJ, Olney AH, Adès L, Maher JF, Guo D, Buja LM, Kim D, Hyland JC, Regalado ES. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A. 2010;152A:2437–2443.
2. Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, Lemaire SA, Coselli JS, Estrera AL, Safi HJ, Veeraraghavan S, Muzni DM, Wheeler DA, Willerson JT, Yu RK, Shete SS, Scherer SE, Raman CS, Buja LM, Milewicz DM. Mutation in SM alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moya moya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617–627.
3. Milewicz DM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S, Kwartler CS, Pannu H. Genetic basis of thoracic aortic aneurysms and dissections: focus on SMC contractile dysfunction. Annu Rev Genomics Hum Genet. 2008;9:283–302.
4. Möller HU, Fledelius HC, Milewicz DM, Regalado ES, Ostergaard JR. Eye features in 3 Danish patients with multisystemic smooth muscle dysfunction syndrome. Br J Ophthalmol. 2012;96:1227–1231.
5. Munot P, Saunders DE, Milewicz DM, Regalado ES, Ostergaard JR, Braun KP, Kerr T, Klaske D, Lichtenbelt KD, Philip S, Rittey C, Jacques TS, Cox TC, Ganesan V. A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutation. Brain. 2012;135:2506–2514.
6. Khan N, Schinzel A, Shuknecht B, Baumann F, Ostergaard JR, Yonekawa Y. Moya-moya angiopathy with dolichoectatic internal carotid artery, patent ductus arteriosus and pupillary dysfunction: a new genetic syndrome? Eur Neurol. 2004;51:72–77.
7. Moosa AN, Traboulsi EI, Reid J, Prieto L, Moran R, Friedman NR. Neonatal stroke and progressive leukoencephalopathy in a child with an ACTA2 mutation. J Child Neurol. 2013;28:531–534.
8. Adès LC, Davies R, Haan EA, Holman KJ, Watson KC, Sreetharan D, Cao S, Milewicz DM, Bateman JF, Chiodo AC, Eccles M, McNoe L, Harbord M. Aortic dissection, patent ductus arteriosus, iris hypoplasia and brachytelephalangy in a male adolescent. Clin Dysmorphol. 1999;8:269–276.
9. Richer J, Milewicz DM, Gow R, de Nanassy J, Maharajh G, Miller E, Oppenheimer L, Weiler G, O’Connor M. R179H mutation in ACTA2 expanding the phenotype to include prune-belly sequence and skin manifestations. Am J Med Genet A. 2012;158A:664–668.
10. Lemire BD, Buncic JR, Kennedy SJ, Dyack SJ, Teebi AS. Congenital mydriasis, patent ductus arteriosus, and congenital cystic lung disease: new syndromic spectrum? Am J Med Genet A. 2004;131A:318–319.
11. Amini R, Whitcomb JE, Al-Qaisi MK, Akkin T, Jouzdani S, Dorairaj S, Prata T, Illitchev E, Liebmann JM, Ritch R, Barocas VH. The posterior location of the dilator muscle induces anterior iris bowing during dilation, even in the absence of pupillary block. Invest Ophthalmol Vis Sci. 2012;53:1188–1194.
12. Tomasek JJ, Haaksma CJ, Schwartz RJ, Vuong DT, Zhang SX, Ash JD, Ma F, Al-Ubaidi MR. Deletion of SM alpha-actin alters blood-retina barrier permeability and retinal function. Invest Ophthalmol Vis Sci. 2006;47:2693–2700.
13. Buys Y, Buncic JR, Enzenauer RW, Mednick E, O'Keefe M. Congenital aplasia of the iris sphincter and dilator muscles. Can J Ophthalmol. 1993;28:72–75.
14. Gräf MH, Jungherr A. Congenital mydriasis, failure of accommodation and patent ductus arteriosus. Arch Ophthalmol. 2002;120:509–510.
15. Gräf M. Bilateral congenital mydriasis and lack of accommodation. Ophthalmologe. 1996;93:377–379.
16. Lindberg K, Brunvand L. Congenital mydriasis combined with aneurysmal dilatation of a persistent ductus arteriosus Botalli: a rare syndrome. Acta Ophthalmol Scand. 2005;83:508–509.
17. Bergström CS. Iris hypoplasia and aorticopulmonary septal defect. J AAPOS. 2005;9:265–267.
18. Marinas ID, Marinas R, Pirici I, Mogoanta L. Vascular and mesenchymal factors during heart development: a chronological study. Rom J Morphol Embryol. 2012;53:135–142.
19. McClelland C, Walsh RD, Chikwava KR, Johnson MP, Mattei P, Liu GT. Congenital mydriasis associated with megacystis microcolon intestinal hypoperistalsis syndrome. J Neuroophthalmol. 2013;33:271–275.
20. Gillespie FD. Aniridia, cerebellar ataxia and oligophrenia in siblings. Arch Ophthalmol. 1965;73:338–341.